1-48534250-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032785.4(AGBL4):c.1435C>A(p.Pro479Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000767 in 1,551,488 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032785.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AGBL4 | NM_032785.4 | c.1435C>A | p.Pro479Thr | missense_variant | 14/14 | ENST00000371839.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AGBL4 | ENST00000371839.6 | c.1435C>A | p.Pro479Thr | missense_variant | 14/14 | 2 | NM_032785.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152090Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000382 AC: 6AN: 157176Hom.: 0 AF XY: 0.0000241 AC XY: 2AN XY: 83134
GnomAD4 exome AF: 0.0000736 AC: 103AN: 1399398Hom.: 0 Cov.: 30 AF XY: 0.0000724 AC XY: 50AN XY: 690192
GnomAD4 genome AF: 0.000105 AC: 16AN: 152090Hom.: 0 Cov.: 32 AF XY: 0.0000808 AC XY: 6AN XY: 74290
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2023 | The c.1435C>A (p.P479T) alteration is located in exon 14 (coding exon 14) of the AGBL4 gene. This alteration results from a C to A substitution at nucleotide position 1435, causing the proline (P) at amino acid position 479 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at